作者：
Maria E,Sheean [1]
;
Eva,Malikova [2]
;
Dinah,Duarte [3]
;
Giuseppe,Capovilla [4]
;
Laura,Fregonese [5]
;
Matthias P,Hofer [5]
;
Armando,Magrelli [6]
;
Segundo,Mariz [5]
;
Fernando,Mendez-Hermida [7]
;
Robert,Nistico [8]
;
Tim,Leest [9]
;
Nikolaos V,Sipsas [10]
;
Stelios,Tsigkos [5]
;
Dinko,Vitezic [11]
;
Kristina,Larsson [5]
;
Bruno,Sepodes [12]
;
Violeta,Stoyanova-Beninska [13]
作者单位：
Orphan Medicines Office, European Medicines Agency, Amsterdam, The Netherlands; Max-Delbrück Center for Molecular Medicine in Helmholz Association, Berlin, Germany. Electronic address: maria.sheean@ema.europa.eu.
[1]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; State Institute for Drug Control, Bratislava, Slovak Republic; Comenius University, Department of Pharmacology and Toxicology, Bratislava, Slovak Republic.
[2]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; INFARMED - Autoridade Nacional do Medicamento, Lisbon, Portugal.
[3]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; C. Poma Hospital, Mantova, Italy; Fondazione Poliambulanza, Brescia, Italy.
[4]
Orphan Medicines Office, European Medicines Agency, Amsterdam, The Netherlands.
[5]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
[6]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
[7]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; Malta Medicines Authority, San Ġwann, Malta.
[8]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; The Federal Agency for Medicines and Health Products, Brussels, Belgium.
[9]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; Medical School, National and Kapodistrian University of Athens, Athens, Greece.
[10]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; University of Rijeka Medical School and University Hospital Centre Rijeka, Rijeka, Croatia.
[11]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; INFARMED - Autoridade Nacional do Medicamento, Lisbon, Portugal; Universidade de Lisboa - Faculdade de Farmácia, Lisbon, Portugal.
[12]
Committee of Orphan Medicinal Products, European Medicines Agency, Amsterdam, The Netherlands; Medicines Evaluation Board, Utrecht, The Netherlands.
[13]
DOI
10.1016/j.drudis.2019.10.015
PMID
31704277
发布时间
2021-04-30
换一批
换一批
